Skip to main content
CDC Website

Generic Programmatic and Clinical Guide for the Introduction of new drugs and Shorter Regimens for the Treatment of Multi/Extensively Drug-Resistant Tuberculosis

This document describes the steps necessary to implement the shorter regimen and the new drugs for drug-resistant TB treatment, including diagnosis and bacterial confirmation of drug resistance, treatment regimen design, monitoring of treatment efficacy and safety, and programmatic evaluation.
Audiences:
Clinics
Health Professionals
Hospitals
Local Government Agencies
State Government Agencies
Author:
KNCV Tuberculosis Foundation/US Agency for International Development
Publication Language:
English
Focus Area:
TB
Subjects:
Case Management
Diagnosis
Treatment Guidelines Materials
Patient Care
TB
Publication Date:
2016
87 p.: col., ill., appendices, refs., tables.